Phase 2 Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are able to read, understand, and communicate in the local language used at the trial site, and are willing to sign a consent form
- You are between 18 and 75 years old (inclusive) at the time of signing the consent form
- You have been diagnosed with recurring depression (meaning you have had at least one episode of depression in the past, separate from your current one), based on standard medical diagnostic guidelines (DSM-5-TR)
Who may not be able to join:
- You are currently pregnant, breastfeeding, or planning to become pregnant during the study
- You have a medical condition or ongoing chronic illness that is not currently stable or well-managed
- You have a significant neurological condition affecting the brain or nervous system (confirm with trial site)
- You have had a moderate or severe problem with alcohol or drug use in the 6 months before your screening appointment, as defined by standard diagnostic guidelines
- You have a history of seizures
- In the opinion of the trial doctor, you may have difficulty following the trial's requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +44(0)2920028450
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in total Montgomery Åsberg depression rating scale (MADRS) score, at Day 56
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.